Capstone Holding Corp. — Director's Dealing 2011

Jan 7, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2011-01-06

Reporting Person: FELDMAN FREDRIC J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-06	Common Stock	P	13000	$0.59	Acquired	190564	Direct